Previous reports suggested that overexpression of BAP1 in lung cancer cells inhibited tumor growth in mice, and BAP1 has few mutations in lung cancer, suggesting that there may be another pathway involved in the dysregulation of BAP1 [17, 25, 26]. Here, BAP1 is linked to lung cancer.